TGF-β signaling can promote tumor progression through immunosuppression (6, 28–30), while TGF-β1 can directly suppress immunosurveillance by inhibiting the anti-tumor activity of infiltrating immune cells and subsequently facilitating the recruitment and sustenance of pro-tumoral immune cells to enhance metastatic progression (20). The gene discussed is TGFB1; the disease is neoplasm.